Pharmacokinetic Interaction Between the HCV Protease Inhibitor MK-5172 and Midazolam, Pitavastatin, and Atorvastatin in Healthy Volunteers

被引：0
|
作者：
Caro, Luzelena [1 ]
Talaty, Jennifer E. [1 ]
Guo, Zifang [2 ]
Reitmann, Christina [3 ]
Fraser, Iain P. [3 ]
Evers, Raymond [4 ]
Swearingen, Dennis [5 ]
Yeh, Wendy W. [3 ]
Butterton, Joan R. [3 ]
机构：
[1] Merck & Co Inc, Clin Drug Metab & Pharmacokinet, Whitehouse Stn, NJ USA
[2] Merck & Co Inc, Early Clin Dev Stat, Whitehouse Stn, NJ USA
[3] Merck & Co Inc, Clin Res, Whitehouse Stn, NJ USA
[4] Merck & Co Inc, Transporter In Vitro Technol, Whitehouse Stn, NJ USA
[5] Celerion, Tempe, AZ USA
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
477
引用
收藏
页码：437A / 438A
页数：2
相关论文
共 50 条
  • [41] USING SHORT-TERM MONOTHERAPY AND IN VITRO DATA TO MAKE EARLY PREDICTIONS OF CLINICAL HCV RESPONSE: EXAMPLES FROM MK-5172, A SECOND GENERATION HCV NS3/4A PROTEASE INHIBITOR
    Nachbar, R. B.
    Stone, J. A.
    Petry, A.
    Poland, B.
    Caro, L.
    Wenning, L. A.
    Khan, A.
    Palcza, J.
    Van Dyck, K.
    Fraser, I.
    Mobashery, N.
    O'Mara, E.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S355 - S356
  • [42] Pharmacokinetic Interaction Between Zolpidem and Carbamazepine in Healthy Volunteers
    Vlase, Laurian
    Popa, Adina
    Neag, Maria
    Muntean, Dana
    Baldea, Ioan
    Leucuta, Sorin E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (08): : 1233 - 1236
  • [43] PHARMACOKINETIC INTERACTION BETWEEN CARBAMAZEPINE AND IVABRADINE IN HEALTHY VOLUNTEERS
    Vlase, L.
    Popa, A.
    Muntean, D.
    Neag, M.
    Leucuta, S. E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 107 - 107
  • [44] The pharmacokinetic interaction between ivacaftor and ritonavir in healthy volunteers
    Liddy, Anne Marie
    McLaughlin, Gavin
    Schmitz, Susanne
    D'Arcy, Deirdre M.
    Barry, Michael G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (10) : 2235 - 2241
  • [45] Pharmacokinetic Interaction Between Prasugrel and Ritonavir in Healthy Volunteers
    Ancrenaz, Virginie
    Deglon, Julien
    Samer, Caroline
    Staub, Christian
    Dayer, Pierre
    Daali, Youssef
    Desmeules, Jules
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (02) : 132 - 137
  • [46] Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers
    Fleishaker, JC
    Sisson, TA
    Carel, BJ
    Azie, NE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (05) : 498 - 503
  • [47] Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers
    Vlase, Laurian
    Leucuta, Adrian
    Farcau, Dorin
    Nanulescu, Mircea
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (06) : 285 - 289
  • [48] No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers
    Cawello, Willi
    Nickel, Brunhild
    Eggert-Formella, Andrea
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04): : 459 - 471
  • [49] Pharmacokinetic Interaction Between Pitavastatin and Valsartan: A Randomized, Open-Labeled Crossover Study in Healthy Male Korean Volunteers
    Jung, Jin Ah
    Noh, Yook-Hwan
    Jin, Seokjoon
    Kim, Mi Jo
    Kim, Yo Han
    Jung, Jin-a
    Lim, Hyeong-Seok
    Bae, Kyun-Seop
    CLINICAL THERAPEUTICS, 2012, 34 (04) : 958 - 965
  • [50] Pharmacokinetic interaction between efavirenz and rifampicin in healthy volunteers
    Yenny
    Nafrialdi
    Djoerban, Z.
    Setiabudy, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (02) : 162 - 168
12345